Moxibustion treatment modulates the gut microbiota and immune function in a dextran sulphate sodium-induced colitis rat model

Figure 1 Body weight gains after treatment in different groups. HC: Healthy controls; UC: UC model group; UC-7: UC model with seven days of moxibustion; UC-14: UC model with fourteen days of moxibustion; UC-W: UC model with mesalazine gavage; HC-7: Healthy controls with seven days of moxibustion; HC-14: healthy controls with fourteen days of moxibustion. The body weight gain in the UC group was decreased compared with the HC group (P < 0.01). After treatment, the body weight gains in the UC-7, UC-14, HC-7, HC-14 (P < 0.01) and UC-W (P < 0.05) groups were increased compared with the UC group. ^bP < 0.01 vs the HC group; ^cP < 0.05, ^dP < 0.01 vs the UC group.